Chemical xenogenization of experimental tumors
Data up to Jan 2025
Total Citations Per Year
Abstract
References (88)
DNA Methylation and Gene Function
1980 • 2,069 citations
Protides of Biological Fluids
1971 • 471 citations
Cancer Metastasis: Experimental Approaches, Theoretical Concepts, and Impacts for Treatment Strategies
1985 • 301 citations
Immunologic Mechanisms in UV Radiation Carcinogenesis
1981 • 295 citations
Teratomas and differentiation
1975 • 252 citations
VIRAL ONCOLYSIS: INCREASED IMMUNOGENICITY OF HOST CELL ANTIGEN ASSOCIATED WITH INFLUENZA VIRUS
1967 • 234 citations
Methylation and gene control
1982 • 210 citations
Antigenic Tumor Cell Variants Obtained with Mutagens
1983 • 166 citations
Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis.
1980 • 162 citations
Rejection by syngeneic mice of cell variants obtained by mutagenesis of a malignant teratocarcinoma cell line.
1977 • 147 citations
Protection against a nonimmunogenic mouse leukemia by an immunogenic variant obtained by mutagenesis.
1982 • 143 citations
Tumour specific immunogenicity of methylcholanthrene-induced sarcoma cells after incubation in neuraminidase.
1969 • 133 citations
Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice.
1980 • 129 citations
Possible epigenetic mechanisms of tumor progression: Induction of high-frequency heritable but phenotypically unstable changes in the tumorigenic and metastatic properties of tumor cell populations by 5-azacytidine treatment
1984 • 125 citations
On the genesis and regulation of cellular heterogeneity in malignant tumors.
1982 • 122 citations
Tumour inhibitory triazenes: Structural requirements for an active metabolite
1976 • 122 citations
IMMUNOLOGICAL ALTERNATION OF LEUKEMIC CELLS In Vivo AFTER TREATMENT WITH AN ANTITUMOR DRUG
1970 • 121 citations
Induction of the metastatic phenotype in a mouse tumor model by 5-azacytidine, and characterization of an antigen associated with metastatic activity.
1984 • 110 citations
Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. I. Parameters for optimal therapeutic effects
1986 • 109 citations
Neoplastic Development 2
1975 • 104 citations
Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. III. Clonal analysis of the syngeneic cytolytic T lymphocyte response
1982 • 89 citations
Effective tumor immunization induced by cells of elevated membrane-lipid microviscosity.
1979 • 89 citations
Teratocarcinoma cell variants rejected by syngeneic mice: protection of mice immunized with these variants against other variants and against the original malignant cell line.
1978 • 88 citations
On a possible epigenetic mechanism(s) of tumor cell heterogeneity
1983 • 87 citations
Selection of strongly immunogenic "tum-" variants from tumors at high frequency using 5-azacytidine.
1984 • 85 citations
Mutagen treatment as a means for selecting immunogenic variants from otherwise poorly immunogenic malignant murine tumors.
1983 • 83 citations
Modification of tumor regression by immunologic means.
1969 • 79 citations
Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtained by mutagenesis.
1983 • 79 citations
Immunogenicity of Leukemia L1210 Cells After Neuraminidase Treatment<xref ref-type="fn" rid="FN1">2</xref>
1972 • 79 citations
Viral Xenogenization of Intact Tumor Cells
1979 • 71 citations
Antigenic changes of L1210 leukemia in mice treated with 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide.
1972 • 71 citations
Antigenicity of L1210 leukemic sublines induced by drugs.
1972 • 66 citations
Virus Augmentation of The Antigenicity of Tumor Cell
1979 • 64 citations
Enhanced Expression of Class I Major Histocompatibility Complex Gene (<italic>D</italic><sup><italic>k</italic></sup>) Products on Immunogenic Variants of a Spontaneous Murine Carcinoma<xref ref-type="fn" rid="FN2">2</xref><xref ref-type="fn" rid="FN3">3</xref>
1985 • 63 citations
Induction of immune responsiveness in a genetically low-responsive tumor-host combination by chemical modification of the immunogen
1976 • 56 citations
Tumor cell variants obtained by mutagenesis of a Lewis lung carcinoma cell line: immune rejection by syngeneic mice.
1979 • 54 citations
Antigenic Changes of L5178Y Lymphoma After Treatment With 5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide In Vivo 2
1976 • 52 citations
Drug-Mediated Antigenic Changes in Murine Leukemia Cells: Antagonistic Effects of Quinacrine, an Antimutagenic Compound23
1980 • 51 citations
Increase in H-2 antigen expression and immunogenicity of BL6 melanoma cells treated with N-methyl-N'-nitronitrosoguanidine.
1985 • 49 citations
Cellular immune response to a drug-treated L5178Y lymphoma subline
1974 • 49 citations
Tumor Associated Antigens and Their Specific Immune Response
1980 • 43 citations
Drug-mediated immunogenic changes of virus-induced leukemia in vivo.
1976 • 41 citations
IN VITRO GENERATION OF PRIMARY CYTOTOXIC LYMPHOCYTES AGAINST L5178Y LEUKEMIA ANTIGENICALLY ALTERED BY 5-(3,3'-DIMETHYL-l-TRIAZENO)-IMIDAZOLE-4-CARBOXAMIDE IN VIVO
1979 • 41 citations
Active specific immunotherapy of minimal residual tumor: Excision plus neuraminidase‐treated tumor cells
1974 • 41 citations
In vitro generation of a highly immunogenic subline of L1210 leukemia following exposure to 5-(3,3'-dimethyl-1-triazeno)imidazole-4-carboxamide.
1981 • 40 citations
Drug-mediated increase of tumor immunogenicity in vivo for a new approach to experimental cancer immunotherapy.
1981 • 38 citations
Effect of 5-azacytidine on DNA methylation and the malignant properties of B16 melanoma cells.
1985 • 35 citations
Radioresistant inhibition of lymphoma growth in congenitally athymic (nude) mice.
1977 • 32 citations
Immunity to lymphoid tumors in syngeneic mice by immunization with mitomycin C-treated cells.
1977 • 32 citations
Neuraminidase Induced Loss in the Transplantability of Murine Leukaemia L 1210, Induction of Immunoprotection and the Transfer of Induced Immunity to Normal DBA/2 Mice by Serum and Peritoneal Cells
1973 • 32 citations
Brief Communication: Increased Immunogenicity of Two Lymphoma Lines After Drug Treatment of Athymic (Nude) Mice
1975 • 30 citations
Drug-Induced Immunogenic Changes of Murine Leukemia Cells: Dissociation of Onset of Resistance and Emergence of Novel Immunogenicity<xref ref-type="fn" rid="FN2">2</xref><xref ref-type="fn" rid="FN3">3</xref>
1983 • 27 citations
Intracerebral Adoptive Immunotherapy of a Murine Lymphoma Antigenically Altered by Drug Treatment In Vivo<xref ref-type="fn" rid="fn2">2</xref>, <xref ref-type="fn" rid="fn3">3</xref>
1982 • 26 citations
Induction of highly immunogenic variants of Lewis lung carcinoma tumor by ultraviolet irradiation.
1985 • 26 citations
Artificial Heterogenization of Tumours by means of Herpes Simplex and Polyoma Viruses
1964 • 25 citations
GROWTH AND REJECTION PATTERNS OF MURINE LYMPHOMA CELLS ANTIGENICALLY ALTERED FOLLOWING DRUG TREATMENT IN VIVO
1978 • 25 citations
Humoral response against murine lymphoma cells xenogenized by drug treatmentin vivo
1985 • 25 citations
Immunogenic changes of murine lymphoma cells following in vitro treatment with aryl-triazene derivatives
1984 • 24 citations
Tum variants: immunogenic variants obtained by mutagen treatment of tumor cells
1985 • 22 citations
Long-term depression of two primary immune responses induced by a single dose of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC)
1978 • 20 citations
Immunosensitivity and histocompatibility antigens in drug-altered leukemic cells.
1976 • 19 citations
Systemic adoptive immunotherapy of a highly immunogenic murine lymphoma growing in the brain
1983 • 19 citations
Adoptive immunotherapy of intracerebral murine lymphomas: Role of different lymphoid populations
1985 • 18 citations
Chemical xenogenization of murine lymphoma cells with triazene derivatives: Immunotoxicological studies
1984 • 18 citations
Immunity to Lymphoid Tumors Induced in Syngeneic Mice by Immunization with Mitomycin C-Treated Cells
1977 • 18 citations
Inhibition of murine lymphoma growth by adoptive transfer of lymphocytes sensitized to a xenogenized tumor variant
1987 • 17 citations
Chemical xenogenization of tumor cells
1985 • 17 citations
Antigenic changes of a murine lymphoma by in vivo treatment with triazene derivatives
1981 • 15 citations
Secondary Cytotoxic Response In Vitro Against Moloney Lymphoma Cells Antigenically Altered by Drug Treatment In Vivo
1978 • 15 citations
Induction of tumor cell rejection in the low responsive YAC-lymphoma strain A host combination by immunization with somatic cell hybrids
1979 • 15 citations
Effects of mutagens on the immunogenicity of tumor cells: comparison of cell surface changes induced by 5-azacytidine and N-methyl-N'-nitro-N-nitrosoguanidine.
1986 • 14 citations
Increased immunogenicity of L1210 leukemia following short-term exposure to 5(3,3?-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) in vivo or in vitro
1979 • 14 citations
Dna methylating activity in murine lymphoma cells xenogenized by triazene derivatives
1987 • 14 citations
Metastatic phenotype of human prostate tumor cells in athymic nude mice: Alteration by exposure to ethyl methanesulfonate and ?reversion? by 5-azacytidine
1986 • 13 citations
Increased immunosensitivity in nitrogen mastard-resistant Yoshida sarcoma.
1973 • 12 citations
Induction of non-transplantable mutant clones from an ascites tumor.
1969 • 12 citations
Appearance of Strong Transplantation Antigens in Non-Immunogenic Lymphoma Following Drug-Treatment In Vivo
1980 • 11 citations
Increased immunogenicity of murine lymphatic tumors by pyrazole-4-carboxamide, 3(or 5)-amino (NSC-1402; PCA).
1973 • 11 citations
Immunogenic cell variants of a mouse teratocarcinoma confer a protection against the original non-immunogenic transplantable tumor
1981 • 10 citations
Monoclonal antibodies to the L1210 murine leukemia cell line and to a drug-altered subline.
1985 • 8 citations
Expression of normal histocompatibility antigens in murine lymphomas treated with 5-(3,3′-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) in vivo
1981 • 7 citations
Influence of glucan on experimental infections in mice
1980 • 6 citations
Tumor-cell Variants With Increased Immunogenicity Obtained By Mutagen Treatment
1985 • 6 citations
Increased frequency of immunogenic variants obtained by repeated mutagen treatment of mouse mastocytoma P815
1983 • 6 citations
Antigenic properties of lymphoma sublines derived from a drug-treated immunogenic L5178Y leukemia.
1978 • 6 citations
Tumour cell variants with increased immunogenicity obtained by mutagen treatment.
1985 • 5 citations
DNA methylating activity in murine lymphoma cells treated with xenogenizing chemicals.
1987 • 2 citations
Immunogenicity of viable tumor cells
1986 • 1 citations